help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nickeleit, V.
Right arrow Articles by Colvin, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nickeleit, V.
Right arrow Articles by Colvin, R. B.

American Journal of Pathology, Vol 147, 965-978, Copyright © 1995 by American Society for Investigative Pathology


REGULAR ARTICLES

Embryonic fibronectin isoforms are synthesized in crescents in experimental autoimmune glomerulonephritis

V Nickeleit, L Zagachin, K Nishikawa, JH Peters, RO Hynes and RB Colvin
Department of Pathology, Massachusetts General Hospital, Boston 02114, USA.

Crescents are a severe and stereotyped glomerular response to injury that occur in several forms of glomerulonephritis that progress to renal failure. The key pathogenetic step that leads to glomerular scarring in unknown, but fibronectin (FN), the clotting system, macrophages, and proliferating parietal epithelial cells are known to participate. This study was designed to determine whether FN is synthesized locally, and in what molecular isoform, and whether cytokines known to promote FN synthesis are present in the crescent. Rats immunized with bovine glomerular basement membrane develop cellular crescents by 14 days and fibrous crescents and glomerulosclerosis by 35 days. In situ hybridization was performed with oligonucleotides specific for sequences common to all FN isoforms (total FN) or sequences specific for the alternatively spliced segments (EIIIA, EIIIB, and V). Throughout the time period (14, 21, and 35 days) all crescents and glomerular tufts contained cells with strong ISH signals for total and V+ mRNA, with the strongest signals present in large cellular crescents at day 21. In contrast, EIIIA+ and EIIIB+ mRNAs showed maximal abundance within sclerosing crescents at 35 days. Protein deposition of EIIIA+, EIIIB+, and V+ FN isoforms was confirmed by immunofluorescence with segment-specific FN antibodies. Transforming growth factor-beta and interleukin-1 beta, both known to promote FN synthesis, were found in cellular crescents (days 14 and 21) and were still present, but greatly diminished, in the sclerotic phase (day 35). In summary, EIIIA-, EIIIB-, and V+ FN mRNA plasma isoforms predominate in cellular crescents, whereas in the fibrosing stage, mainly the oncofetal EIIIA+, EIIIB+, and V+ isoforms are synthesized and accumulate.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Zuk, J. V. Bonventre, and K. S. Matlin
Expression of fibronectin splice variants in the postischemic rat kidney
Am J Physiol Renal Physiol, June 1, 2001; 280(6): F1037 - F1053.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. J. Coito, K. Onodera, H. Kato, R. W. Busuttil, and J. W. Kupiec-Weglinski
Fibronectin-Mononuclear Cell Interactions Regulate Type 1 Helper T Cell Cytokine Network in Tolerant Transplant Recipients
Am. J. Pathol., October 1, 2000; 157(4): 1207 - 1218.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-F. Liao, K. G. Wieder, J. M. Classen, and L. V. De Water
Identification of Two Amino Acids within the EIIIA (ED-A) Segment of Fibronectin Constituting the Epitope for Two Function-blocking Monoclonal Antibodies
J. Biol. Chem., June 18, 1999; 274(25): 17876 - 17884.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
V. L. Barnes, J. Musa, R. J. Mitchell, and J. L. Barnes
Expression of Embryonic Fibronectin Isoform EIIIA Parallels {alpha}-Smooth Muscle Actin in Maturing and Diseased Kidney
J. Histochem. Cytochem., June 1, 1999; 47(6): 787 - 798.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
A. R. Allen, J. McHale, J. Smith, H. T. Cook, A. Karkar, D. O. Haskard, R. R. Lobb, and C. D. Pusey
Endothelial Expression of VCAM-1 in Experimental Crescentic Nephritis and Effect of Antibodies to Very Late Antigen-4 or VCAM-1 on Glomerular Injury
J. Immunol., May 1, 1999; 162(9): 5519 - 5527.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society for Investigative Pathology.